Increased targeted HIV testing and reduced undiagnosed HIV infections among gay and bisexual men
© 2021 British HIV Association..
OBJECTIVES: To evaluate the impact of government HIV strategies that aimed to increase HIV testing uptake and frequency among gay and bisexual men (GBM) in New South Wales (NSW), Australia.
DESIGN: We analysed HIV testing data from existing passive and sentinel surveillance systems between 2010 and 2018.
METHODS: Six indicators were measured: (1) state-wide total HIV laboratory tests; (2) number of GBM attending publicly-funded clinics; (3) 12-monthly testing uptake; (4) annual testing frequency; (5) HIV testing with a STI diagnosis; and (6) HIV positivity. Mathematical modelling was used to estimate (7) the proportion of men with undiagnosed HIV. Indicators were stratified by Australian vs. overseas-born.
RESULTS: Overall, 43,560 GBM attended participating clinics (22,662 Australian-born, 20,834 overseas-born) from 2010-2018. Attendees increased from 5,186 in 2010 to 16,507 in 2018. There were increasing trends (p<0.001 for all) in testing uptake (83.9% to 95.1%); testing with a STI diagnosis (68.7% to 94.0%); annual HIV testing frequency (1.4 to 2.7); and a decreasing trend (p<0.01) in HIV positivity (1.7% to 0.9%).Increases in testing were similar in Australian-born and overseas-born GBM. However, there were decreasing trends in the estimated undiagnosed HIV proportion overall (9.5% to 7.7%) and in Australian-born GBM (7.1% to 2.8%), but an increasing trend in overseas-born GBM (15.3% to 16.9%) (p<0.001 for all).
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
HIV medicine - 22(2021), 7 vom: 05. Aug., Seite 605-616 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Patel, P G [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Gay and bisexual men |
|---|
| Anmerkungen: |
Date Completed 14.03.2022 Date Revised 14.03.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/hiv.13102 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM324310560 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM324310560 | ||
| 003 | DE-627 | ||
| 005 | 20231225190037.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/hiv.13102 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1080.xml |
| 035 | |a (DE-627)NLM324310560 | ||
| 035 | |a (NLM)33876526 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Patel, P G |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Increased targeted HIV testing and reduced undiagnosed HIV infections among gay and bisexual men |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.03.2022 | ||
| 500 | |a Date Revised 14.03.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021 British HIV Association. | ||
| 520 | |a OBJECTIVES: To evaluate the impact of government HIV strategies that aimed to increase HIV testing uptake and frequency among gay and bisexual men (GBM) in New South Wales (NSW), Australia | ||
| 520 | |a DESIGN: We analysed HIV testing data from existing passive and sentinel surveillance systems between 2010 and 2018 | ||
| 520 | |a METHODS: Six indicators were measured: (1) state-wide total HIV laboratory tests; (2) number of GBM attending publicly-funded clinics; (3) 12-monthly testing uptake; (4) annual testing frequency; (5) HIV testing with a STI diagnosis; and (6) HIV positivity. Mathematical modelling was used to estimate (7) the proportion of men with undiagnosed HIV. Indicators were stratified by Australian vs. overseas-born | ||
| 520 | |a RESULTS: Overall, 43,560 GBM attended participating clinics (22,662 Australian-born, 20,834 overseas-born) from 2010-2018. Attendees increased from 5,186 in 2010 to 16,507 in 2018. There were increasing trends (p<0.001 for all) in testing uptake (83.9% to 95.1%); testing with a STI diagnosis (68.7% to 94.0%); annual HIV testing frequency (1.4 to 2.7); and a decreasing trend (p<0.01) in HIV positivity (1.7% to 0.9%).Increases in testing were similar in Australian-born and overseas-born GBM. However, there were decreasing trends in the estimated undiagnosed HIV proportion overall (9.5% to 7.7%) and in Australian-born GBM (7.1% to 2.8%), but an increasing trend in overseas-born GBM (15.3% to 16.9%) (p<0.001 for all) | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a HIV infections | |
| 650 | 4 | |a HIV testing | |
| 650 | 4 | |a gay and bisexual men | |
| 650 | 4 | |a sentinel surveillance | |
| 650 | 4 | |a undiagnosed HIV | |
| 700 | 1 | |a Keen, P |e verfasserin |4 aut | |
| 700 | 1 | |a McManus, H |e verfasserin |4 aut | |
| 700 | 1 | |a Duck, T |e verfasserin |4 aut | |
| 700 | 1 | |a Callander, D |e verfasserin |4 aut | |
| 700 | 1 | |a Selvey, C |e verfasserin |4 aut | |
| 700 | 1 | |a Power, C |e verfasserin |4 aut | |
| 700 | 1 | |a Gray, R T |e verfasserin |4 aut | |
| 700 | 1 | |a Knight, V |e verfasserin |4 aut | |
| 700 | 1 | |a Asselin, J |e verfasserin |4 aut | |
| 700 | 1 | |a Read, P |e verfasserin |4 aut | |
| 700 | 1 | |a Johnson, K |e verfasserin |4 aut | |
| 700 | 1 | |a Bavinton, B R |e verfasserin |4 aut | |
| 700 | 1 | |a Bowden, V J |e verfasserin |4 aut | |
| 700 | 1 | |a Grulich, A E |e verfasserin |4 aut | |
| 700 | 1 | |a Guy, R |e verfasserin |4 aut | |
| 700 | 0 | |a NSW HIV Prevention Partnership Project |e verfasserin |4 aut | |
| 700 | 1 | |a Grulich, Andrew |e investigator |4 oth | |
| 700 | 1 | |a Selvey, Christine |e investigator |4 oth | |
| 700 | 1 | |a Guy, Rebecca |e investigator |4 oth | |
| 700 | 1 | |a Prestage, Garrett |e investigator |4 oth | |
| 700 | 1 | |a Zablotska, Iryna |e investigator |4 oth | |
| 700 | 1 | |a Holden, Jo |e investigator |4 oth | |
| 700 | 1 | |a Cooper, Craig |e investigator |4 oth | |
| 700 | 1 | |a Price, Karen |e investigator |4 oth | |
| 700 | 1 | |a Holt, Martin |e investigator |4 oth | |
| 700 | 1 | |a de Wit, John |e investigator |4 oth | |
| 700 | 1 | |a Kaldor, John |e investigator |4 oth | |
| 700 | 1 | |a Kelleher, Anthony |e investigator |4 oth | |
| 700 | 1 | |a Wilson, David |e investigator |4 oth | |
| 700 | 1 | |a Brotherton, Alan |e investigator |4 oth | |
| 700 | 1 | |a Cooper, David A |e investigator |4 oth | |
| 700 | 1 | |a Crooks, Levinia |e investigator |4 oth | |
| 700 | 1 | |a Whittaker, Bill |e investigator |4 oth | |
| 700 | 1 | |a Madeddu, Daniel |e investigator |4 oth | |
| 700 | 1 | |a Schmidt, Heather-Marie |e investigator |4 oth | |
| 700 | 1 | |a Telfer, Barbara |e investigator |4 oth | |
| 700 | 1 | |a Price, Karen |e investigator |4 oth | |
| 700 | 1 | |a Boyd, Mark |e investigator |4 oth | |
| 700 | 1 | |a Cooper, Craig |e investigator |4 oth | |
| 700 | 1 | |a McGill, Scott |e investigator |4 oth | |
| 700 | 1 | |a Pinto, Angie |e investigator |4 oth | |
| 700 | 1 | |a Nigro, Steven |e investigator |4 oth | |
| 700 | 1 | |a Gordon, Tina |e investigator |4 oth | |
| 700 | 1 | |a Feeney, Lance |e investigator |4 oth | |
| 700 | 1 | |a Cunningham, Philip |e investigator |4 oth | |
| 700 | 1 | |a Mao, Limin |e investigator |4 oth | |
| 700 | 1 | |a Gray, James |e investigator |4 oth | |
| 700 | 1 | |a O'Dwyer, Matthew |e investigator |4 oth | |
| 700 | 1 | |a Clifton, Brent |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t HIV medicine |d 1999 |g 22(2021), 7 vom: 05. Aug., Seite 605-616 |w (DE-627)NLM116282541 |x 1468-1293 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2021 |g number:7 |g day:05 |g month:08 |g pages:605-616 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/hiv.13102 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2021 |e 7 |b 05 |c 08 |h 605-616 | ||